Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA)

The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.

Proceedings of the Association of American Physicians·1999

Insulin resistance and thrombosis: a cardiologist's view.

The American journal of cardiology·1999

Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.

Thrombosis research·1999

TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes.

The American journal of physiology·1999

Cardiovascular consequences of polycystic ovary syndrome.

Endocrinology and metabolism clinics of North America·1999

The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo.

Atherosclerosis·1999

Multilayered clearance concept: a membrane-resolved flux framework for drug metabolism.

Biochemical pharmacology·2026

Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.

Biochemical pharmacology·2026

Allosteric kinase inhibition in hematological malignancies: from asciminib to emerging regulatory sites.

Biochemical pharmacology·2026

Connexin-43 remodeling drives atrial arrhythmias in hypothyroidism: ranolazine as a potential therapeutic strategy.

Biochemical pharmacology·2026

MANF attenuates cholestatic liver injury by enhancing GRP78-PERK interaction.

Biochemical pharmacology·2026

Schisantherin B mitigates cisplatin-induced ototoxicity by modulating the CNPY2-PERK/CHOP signaling axis.

Biochemical pharmacology·2026

Conventional and hydrolysable PEGs: comparative evaluation of tissue accumulation, biodistribution and toxicological profile.

Biomaterials science·2026

When Tapering Is Not an Option: Transitioning From High-Dose Methadone to Buprenorphine.

Cureus·2026

The Laws of Bariatric Pheromonology.

JPMA. The Journal of the Pakistan Medical Association·2026

Poisons causing acute kidney injury in Indo-Pak region: A meta-analysis.

JPMA. The Journal of the Pakistan Medical Association·2026

Choroid Plexus Microstructural Alterations Link Glymphatic Dysfunction and White Matter Degeneration in Parkinson's Disease.

CNS neuroscience & therapeutics·2026

Drug utilisation and adverse drug reaction monitoring in schizophrenic patients: A tertiary care hospital study in India.

Bioinformation·2026

Related Experiment Videos

Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA)

Related Concept Videos

The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.

Insulin resistance and thrombosis: a cardiologist's view.

Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.

TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes.

Cardiovascular consequences of polycystic ovary syndrome.

The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo.

Multilayered clearance concept: a membrane-resolved flux framework for drug metabolism.

Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.

Allosteric kinase inhibition in hematological malignancies: from asciminib to emerging regulatory sites.

Connexin-43 remodeling drives atrial arrhythmias in hypothyroidism: ranolazine as a potential therapeutic strategy.

MANF attenuates cholestatic liver injury by enhancing GRP78-PERK interaction.

Schisantherin B mitigates cisplatin-induced ototoxicity by modulating the CNPY2-PERK/CHOP signaling axis.

Conventional and hydrolysable PEGs: comparative evaluation of tissue accumulation, biodistribution and toxicological profile.

When Tapering Is Not an Option: Transitioning From High-Dose Methadone to Buprenorphine.

The Laws of Bariatric Pheromonology.

Poisons causing acute kidney injury in Indo-Pak region: A meta-analysis.

Choroid Plexus Microstructural Alterations Link Glymphatic Dysfunction and White Matter Degeneration in Parkinson's Disease.

Drug utilisation and adverse drug reaction monitoring in schizophrenic patients: A tertiary care hospital study in India.

Related Experiment Videos

Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA)

Related Concept Videos

Related Articles